Lammert describes the lack of developments in autoimmune hepatitis care over the past several decades and points to what might be next in disease management.
Craig Lammert, MD
Advertisement
Craig Lammert, MD, is an associate professor of medicine at Indiana University School of Medicine and executive director for the Autoimmune Hepatitis Association.
Articles by Craig Lammert, MD
Lammert describes the clinical impact of having 2 new second-line PBC therapies, challenges to their uptake, and areas where more research is needed.
Lammert discusses the shifting landscape of treatment response metrics and the latest advancements in second-line therapy for PBC.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
2
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
3
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
4
What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD
5